SCHEMBL31712581

SCHEMBL31712581

C=C1CN2CC(=C)CC2(COc2nc(OCC[Si](C)(C)C)c3cnc(Cl)c(F)c3n2)C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 13/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26981362 0.92 KRAS (0.42) KRAS
SCHEMBL30706977 0.85 KRAS (0.35) KRAS
SCHEMBL26981311 0.83 KRAS (0.44) KRAS
SCHEMBL30706827 0.77 KRAS (0.43) KRAS
SCHEMBL30707010 0.74 KRAS (0.41) KRAS
SCHEMBL26981407 0.73 — —
SCHEMBL27159256 0.72 KRAS (0.41) KRAS
SCHEMBL31712569 0.71 KRAS (0.43) KRAS
SCHEMBL30734051 0.71 KRAS (0.38) KRAS
SCHEMBL27204310 0.71 KRAS (0.36) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4640684-A1 KRAS G12D INHIBITORS AND USES THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2025-10-29 — — EP disclosed
Send feedback